SOLVAY PHARMACEUTICALS, INC. BECOMES SIGNATORY TO PHRMA'S CONSUMER ADVERTISING 'GUIDING PRINCIPLES'

Responding to the concerns of consumers, patients and health care professionals, Solvay Pharmaceuticals, Inc. has become a signatory to the pharmaceutical industry's "Guiding Principles" on direct-to-consumer (DTC) advertising. "Solvay Pharmaceuticals believes there is a significant public health benefit to be gained from direct-to-consumer advertising by driving patients into their healthcare provider's office for information, rather than remaining silent on their health issues," said Harold H. Shlevin, Ph.D., President and CEO of Solvay Pharmaceuticals, Inc. and member of The Pharmaceutical Research and Manufacturers of America (PhRMA) Board of Directors.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050803005518&newsLang=en)